Alterations of cerebrospinal fluid 5-hydroxyindoleacetic acid, and total blood serotonin content during clozapine treatment
- 1 January 1978
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 56 (2) , 195-198
- https://doi.org/10.1007/bf00431849
Abstract
Cerebrospinal fluid 5-hydroxyindoleacetic acid level, and total blood serotonin content was measured in groups of manic and schizophrenic patients before and after 2, 4, 6, 10, 20, and 30 days of clozapine treatment. CSF 5-HIAA values were elevated after 2 and 4 days and returned to baseline levels after 6 days or more. Blood serotonin content, in contrast, increased gradually and remained high even after 30 days. Neither CSF 5-HIAA nor blood 5-HT correlated with age, drug dose, or clinical effectiveness, but some relationship between these and the sedative component of the clozapine action was observed.This publication has 34 references indexed in Scilit:
- Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disordersJournal of Neurochemistry, 1977
- TOTAL 5-HYDROXYINDOLES IN BLOOD RELATED to MIGRAINE ATTACKSActa Neurologica Scandinavica, 1976
- Human sleep and 5-HTP. Effects of repeated high doses and of association with benserazide (RO.04.4602)Electroencephalography and Clinical Neurophysiology, 1976
- Effect of antipsychotic drugs on the firing of dorsal raphe cells. II. Reversal by picrotoxinEuropean Journal of Pharmacology, 1976
- Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic systemEuropean Journal of Pharmacology, 1976
- CLOZAPINE AND AGRANULOCYTOSISThe Lancet, 1975
- A simple routine-method to preserve and determine blood serotoninCellular and Molecular Life Sciences, 1974
- Increase of morphine-induced analgesia by stimulation of the nucleus raphe dorsalisEuropean Journal of Pharmacology, 1971
- Ergebnisse eines Doppelblindversuches von HF 1854*(8-Chlor-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b, e) (1,4) diazepin) im Vergleich zu LevomepromazinPharmacopsychiatry, 1971
- Biogenic Amines and the States of SleepScience, 1969